Cannabinoids for treating inflammatory bowel diseases: where are we and where do we go?

Carina Hasenöhrl (First author)
, M Storr
, Rudolf Schicho (Last author)

Division of Pharmacology

Research output: Contribution to journal › Review

55 Citations (Web of Science)

Original language	English
Journal	Expert Review of Gastroenterology and Hepatology
DOIs	https://doi.org/10.1080/17474124.2017.1292851
Publication status	Published - 2017

Branches of science

301 Medical-Theoretical Sciences, Pharmacy
302 Clinical Medicine

DOI

10.1080/17474124.2017.1292851

Links

Cite this

@article{559094e15ac2408a9b3d9147d1b90640,

title = "Cannabinoids for treating inflammatory bowel diseases: where are we and where do we go?",

author = "Carina Hasen{\"o}hrl and M Storr and Rudolf Schicho",

year = "2017",

doi = "10.1080/17474124.2017.1292851",

language = "English",

journal = "Expert Review of Gastroenterology and Hepatology",

issn = "1747-4124",

publisher = "Taylor and Francis Ltd.",

}

TY - JOUR

T1 - Cannabinoids for treating inflammatory bowel diseases: where are we and where do we go?

AU - Storr, M

A2 - Hasenöhrl, Carina

A2 - Schicho, Rudolf

PY - 2017

Y1 - 2017

UR - https://www.webofscience.com/wos/woscc/full-record/WOS:000396876900007

UR - https://pubmed.ncbi.nlm.nih.gov/28276820

UR - https://pmc.ncbi.nlm.nih.gov/articles/PMC5388177

U2 - 10.1080/17474124.2017.1292851

DO - 10.1080/17474124.2017.1292851

M3 - Review

C2 - 28276820

SN - 1747-4124

JO - Expert Review of Gastroenterology and Hepatology

JF - Expert Review of Gastroenterology and Hepatology

ER -